What is NDC 71921-408?

71921-408 is the product NDC for Rasagiline mesylate, Rasagiline mesylate 1 mg/1 tablet, listed with the FDA by Florida Pharmaceutical Products, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Florida Pharmaceutical Products, LLC, NDC labeler code 71921. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rasagiline mesylate?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rasagiline mesylate NDC 71921-408 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71921-408Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71921-0408Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71921-408-33	7192104083371921040833	30 TABLET in 1 BOTTLE (71921-408-33)Marketed from Apr 14, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rasagiline mesylate
Generic name (nonproprietary): rasagiline mesylate
Active ingredients: Rasagiline mesylate — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Florida Pharmaceutical Products, LLCNDC labeler code 71921
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206153
Marketing start: Apr 14, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Monoamine Oxidase Inhibitors (Mechanism)
Identifiers: Product ID 71921-408_3b57a1c9-0ad9-40cf-a972-29851a658489SPL ID 3b57a1c9-0ad9-40cf-a972-29851a658489SPL set ID 3b57a1c9-0ad9-40cf-a972-29851a658489RxCUI 608328, 636664UNII LH8C2JI290UPC 0371921407330
Pharmacologic class: Monoamine Oxidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471921040833 followed by a unit qualifier and the quantity

Package 71921-0408-33. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 23, 2026.

Indications (excerpt from the label)

Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD). Rasagiline tablets, a monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson's disease

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71921-408

What is NDC 71921-408?: 71921-408 is the product NDC for Rasagiline mesylate, Rasagiline mesylate 1 mg/1 tablet, listed with the FDA by Florida Pharmaceutical Products, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rasagiline mesylate.
What is the active ingredient?: Rasagiline mesylate.
Who is the labeler?: Florida Pharmaceutical Products, LLC, NDC labeler code 71921. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rasagiline mesylate?: 1 other product NDC are listed under this name. See all Rasagiline mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rasagiline mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-407	71921-0407-33

Other NDCs under ANDA 206153

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206153
Product	Strength	Form · route	Labeler	Product NDC
Rasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-407